HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment

Roberta Valsecchi, Nadia Coltella, Daniela Belloni, Manfredi Ponente, Elisa Ten Hacken, Cristina Scielzo, Lydia Scarfò, Maria Teresa Sabrina Bertilaccio, Paola Brambilla, Elisa Lenti, Filippo Martinelli Boneschi, Andrea Brendolan, Elisabetta Ferrero, Marina Ferrarini, Paolo Ghia, Giovanni Tonon, Maurilio Ponzoni, Federico Caligaris-Cappio, Rosa Bernardi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Hypoxia-inducible transcription factors (HIFs) regulate a wide array of adaptive responses to hypoxia and are often activated in solid tumors and hematologic malignancies due to intratumoral hypoxia and emerging new layers of regulation. We found that in chronic lymphocytic leukemia (CLL), HIF-1α is a novel regulator of the interaction of CLL cells with protective leukemia microenvironments and, in turn, is regulated by this interaction in a positive feedback loop that promotes leukemia survival and propagation. Through unbiased microarray analysis, we found that in CLL cells, HIF-1α regulates the expression of important chemokine receptors and cell adhesion molecules that control the interaction of leukemic cells with bone marrow and spleen microenvironments. Inactivation of HIF-1α impairs chemotaxis and cell adhesion to stroma, reduces bone marrow and spleen colonization in xenograft and allograft CLL mouse models, and prolongs survival in mice. Of interest, we found that in CLL cells, HIF-1α is transcriptionally regulated after coculture with stromal cells. Furthermore, HIF-1α messenger RNA levels vary significantly within CLL patients and correlate with the expression of HIF-1α target genes, including CXCR4, thus further emphasizing the relevance of HIF-1α expression to CLL pathogenesis.

Original languageEnglish
Pages (from-to)1987-1997
Number of pages11
JournalBlood
Volume127
Issue number16
DOIs
Publication statusPublished - 2016

Fingerprint

Hypoxia-Inducible Factor 1
Tumor Microenvironment
B-Cell Chronic Lymphocytic Leukemia
Tumors
Transcription Factors
Cell Hypoxia
Bone
Leukemia
Spleen
Survival
Chemokine Receptors
Cell adhesion
Cell Adhesion Molecules
Hematologic Neoplasms
Chemotaxis
Microarray Analysis
Microarrays
Stromal Cells
Coculture Techniques
Heterografts

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

Cite this

Valsecchi, R., Coltella, N., Belloni, D., Ponente, M., Ten Hacken, E., Scielzo, C., ... Bernardi, R. (2016). HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment. Blood, 127(16), 1987-1997. https://doi.org/10.1182/blood-2015-07-657056

HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment. / Valsecchi, Roberta; Coltella, Nadia; Belloni, Daniela; Ponente, Manfredi; Ten Hacken, Elisa; Scielzo, Cristina; Scarfò, Lydia; Bertilaccio, Maria Teresa Sabrina; Brambilla, Paola; Lenti, Elisa; Boneschi, Filippo Martinelli; Brendolan, Andrea; Ferrero, Elisabetta; Ferrarini, Marina; Ghia, Paolo; Tonon, Giovanni; Ponzoni, Maurilio; Caligaris-Cappio, Federico; Bernardi, Rosa.

In: Blood, Vol. 127, No. 16, 2016, p. 1987-1997.

Research output: Contribution to journalArticle

Valsecchi, R, Coltella, N, Belloni, D, Ponente, M, Ten Hacken, E, Scielzo, C, Scarfò, L, Bertilaccio, MTS, Brambilla, P, Lenti, E, Boneschi, FM, Brendolan, A, Ferrero, E, Ferrarini, M, Ghia, P, Tonon, G, Ponzoni, M, Caligaris-Cappio, F & Bernardi, R 2016, 'HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment', Blood, vol. 127, no. 16, pp. 1987-1997. https://doi.org/10.1182/blood-2015-07-657056
Valsecchi R, Coltella N, Belloni D, Ponente M, Ten Hacken E, Scielzo C et al. HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment. Blood. 2016;127(16):1987-1997. https://doi.org/10.1182/blood-2015-07-657056
Valsecchi, Roberta ; Coltella, Nadia ; Belloni, Daniela ; Ponente, Manfredi ; Ten Hacken, Elisa ; Scielzo, Cristina ; Scarfò, Lydia ; Bertilaccio, Maria Teresa Sabrina ; Brambilla, Paola ; Lenti, Elisa ; Boneschi, Filippo Martinelli ; Brendolan, Andrea ; Ferrero, Elisabetta ; Ferrarini, Marina ; Ghia, Paolo ; Tonon, Giovanni ; Ponzoni, Maurilio ; Caligaris-Cappio, Federico ; Bernardi, Rosa. / HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment. In: Blood. 2016 ; Vol. 127, No. 16. pp. 1987-1997.
@article{8d5e8a57259640de8c05dd851fd9e553,
title = "HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment",
abstract = "Hypoxia-inducible transcription factors (HIFs) regulate a wide array of adaptive responses to hypoxia and are often activated in solid tumors and hematologic malignancies due to intratumoral hypoxia and emerging new layers of regulation. We found that in chronic lymphocytic leukemia (CLL), HIF-1α is a novel regulator of the interaction of CLL cells with protective leukemia microenvironments and, in turn, is regulated by this interaction in a positive feedback loop that promotes leukemia survival and propagation. Through unbiased microarray analysis, we found that in CLL cells, HIF-1α regulates the expression of important chemokine receptors and cell adhesion molecules that control the interaction of leukemic cells with bone marrow and spleen microenvironments. Inactivation of HIF-1α impairs chemotaxis and cell adhesion to stroma, reduces bone marrow and spleen colonization in xenograft and allograft CLL mouse models, and prolongs survival in mice. Of interest, we found that in CLL cells, HIF-1α is transcriptionally regulated after coculture with stromal cells. Furthermore, HIF-1α messenger RNA levels vary significantly within CLL patients and correlate with the expression of HIF-1α target genes, including CXCR4, thus further emphasizing the relevance of HIF-1α expression to CLL pathogenesis.",
author = "Roberta Valsecchi and Nadia Coltella and Daniela Belloni and Manfredi Ponente and {Ten Hacken}, Elisa and Cristina Scielzo and Lydia Scarf{\`o} and Bertilaccio, {Maria Teresa Sabrina} and Paola Brambilla and Elisa Lenti and Boneschi, {Filippo Martinelli} and Andrea Brendolan and Elisabetta Ferrero and Marina Ferrarini and Paolo Ghia and Giovanni Tonon and Maurilio Ponzoni and Federico Caligaris-Cappio and Rosa Bernardi",
year = "2016",
doi = "10.1182/blood-2015-07-657056",
language = "English",
volume = "127",
pages = "1987--1997",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "16",

}

TY - JOUR

T1 - HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment

AU - Valsecchi, Roberta

AU - Coltella, Nadia

AU - Belloni, Daniela

AU - Ponente, Manfredi

AU - Ten Hacken, Elisa

AU - Scielzo, Cristina

AU - Scarfò, Lydia

AU - Bertilaccio, Maria Teresa Sabrina

AU - Brambilla, Paola

AU - Lenti, Elisa

AU - Boneschi, Filippo Martinelli

AU - Brendolan, Andrea

AU - Ferrero, Elisabetta

AU - Ferrarini, Marina

AU - Ghia, Paolo

AU - Tonon, Giovanni

AU - Ponzoni, Maurilio

AU - Caligaris-Cappio, Federico

AU - Bernardi, Rosa

PY - 2016

Y1 - 2016

N2 - Hypoxia-inducible transcription factors (HIFs) regulate a wide array of adaptive responses to hypoxia and are often activated in solid tumors and hematologic malignancies due to intratumoral hypoxia and emerging new layers of regulation. We found that in chronic lymphocytic leukemia (CLL), HIF-1α is a novel regulator of the interaction of CLL cells with protective leukemia microenvironments and, in turn, is regulated by this interaction in a positive feedback loop that promotes leukemia survival and propagation. Through unbiased microarray analysis, we found that in CLL cells, HIF-1α regulates the expression of important chemokine receptors and cell adhesion molecules that control the interaction of leukemic cells with bone marrow and spleen microenvironments. Inactivation of HIF-1α impairs chemotaxis and cell adhesion to stroma, reduces bone marrow and spleen colonization in xenograft and allograft CLL mouse models, and prolongs survival in mice. Of interest, we found that in CLL cells, HIF-1α is transcriptionally regulated after coculture with stromal cells. Furthermore, HIF-1α messenger RNA levels vary significantly within CLL patients and correlate with the expression of HIF-1α target genes, including CXCR4, thus further emphasizing the relevance of HIF-1α expression to CLL pathogenesis.

AB - Hypoxia-inducible transcription factors (HIFs) regulate a wide array of adaptive responses to hypoxia and are often activated in solid tumors and hematologic malignancies due to intratumoral hypoxia and emerging new layers of regulation. We found that in chronic lymphocytic leukemia (CLL), HIF-1α is a novel regulator of the interaction of CLL cells with protective leukemia microenvironments and, in turn, is regulated by this interaction in a positive feedback loop that promotes leukemia survival and propagation. Through unbiased microarray analysis, we found that in CLL cells, HIF-1α regulates the expression of important chemokine receptors and cell adhesion molecules that control the interaction of leukemic cells with bone marrow and spleen microenvironments. Inactivation of HIF-1α impairs chemotaxis and cell adhesion to stroma, reduces bone marrow and spleen colonization in xenograft and allograft CLL mouse models, and prolongs survival in mice. Of interest, we found that in CLL cells, HIF-1α is transcriptionally regulated after coculture with stromal cells. Furthermore, HIF-1α messenger RNA levels vary significantly within CLL patients and correlate with the expression of HIF-1α target genes, including CXCR4, thus further emphasizing the relevance of HIF-1α expression to CLL pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84993661726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84993661726&partnerID=8YFLogxK

U2 - 10.1182/blood-2015-07-657056

DO - 10.1182/blood-2015-07-657056

M3 - Article

VL - 127

SP - 1987

EP - 1997

JO - Blood

JF - Blood

SN - 0006-4971

IS - 16

ER -